European Markets for Total Joint Replacement Products

Musculoskeletal diseases and disorders are a leading cause of disability in Europe. Total joint replacement may be indicated to provide long-term pain relief and restoration of function for patients with diseased or damaged joints.

This report presents an overview of the European market for total joint replacement systems including total hip, knee, shoulder, and elbow replacements. During the forecast period covered by this report, many of the market segments are expected to realize steady growth, with overall procedure volumes for total joint replacements increasing at a compound annual rate of 5.4% and sales volumes projected to grow at a compound annual rate of 5.8%.

Growth in the European total joint replacements products market will be driven by factors such as the expanding elderly segment of the population, technological advances in joint replacement implants and arthroplasty techniques, increases in the number of revision and minimally invasive procedures, and the devaluation of the United States dollar.

At the same time that growth is occurring in the European total joint replacement market, limitations will occur as a result of several converging factors including cost constraints that have been imposed by national healthcare systems, delay of product launches as a result of government regulations requiring evidence of product efficacy, pricing pressures due to the requirement for competitive bids, and lengthy delays in device reimbursements on the part of certain European countries.